Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn
Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn
Recruiting · NCT04218318 · Registry updated 2025-01-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safe Threshold to Discontinue Phototherapy in Hemolytic Disease of Newborn | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Fetal Diseases, Hemic and Lymphatic Diseases, Hemolysis, Hyperbilirubinemia, Neonatal, Infant, Newborn, Diseases, Jaundice, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, Urogenital Diseases, fetal erythroblastosis, hematologic disorder, hyperbilirubinemia, immune system disorder, pregnancy disorder | Recruiting | Not applicable | 2025-01-03 | NCT04218318 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ministry of Health, Saudi Arabia | 7 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Madinah maternity and children's hospital | Madinah | Saudi Arabia | 1 |